Posted December 22, 2016
The 996 page Act has been promoted by Congress as a consumer friendly bill to fund medical research and make new prescription drugs and medical devices more quickly available in the U.S., but it also lowers licensing standards used by the Food and Drug Administration (FDA) to fast track experimental vaccines to market that will be federally recommended and state mandated for use by all children and many adults in America. Read more.